Research & Innovation
UAB is renewed for another five years in NeuroNEXT, a national clinical research program in brain disorders.
UAB was part of a groundbreaking trial that is believed to be the first time it has been proved that the risk of mild cognitive impairment and dementia can be reduced through high blood-pressure treatment.
Researchers found that prolonged oxygen supplementation adversely affected the development of memory function in preterm infants.
Two new studies will have an intriguing mix of catalysts, “tunable” chemical bonds, supercomputers and ultrafast lasers.
UAB in Antarctica has fruitful research season on Earth’s southernmost continent.
A gene mutation causes wrinkled skin and hair loss; turning off that mutation restores the mouse to normal appearance.
The mechanism the tuberculosis pathogen uses in its escape suggests possible therapies to improve patient outcomes.
Significant novel findings published by UAB researchers established verapamil as a successful therapeutic approach to target loss of beta cell function caused by Type 1 diabetes.
A gene called TXNIP was the answer, and it led to a drug called verapamil and a successful diabetes trial.

Biomedical scientists and engineers can participate in a nationwide program that helps take their discoveries from the research lab to the clinical setting.

A diabetes drug suggests potential therapy for idiopathic pulmonary fibrosis, based on research with human lung fibroblasts and a mouse model of lung fibrosis.
A UAB researcher hopes to use new data tools to find answers to a dangerous form of epilepsy.
UAB is one of six universities in the world currently investigating the medicinal benefits of psilocybin.
These immune cells could become therapeutic targets to treat Crohn’s disease and ulcerative colitis.
In a large-scale analysis, Jeremy Blackburn, Ph.D., and collaborators found that the misuse of web archive services cause loss of ad revenue for popular news websites.
Tensor completion algorithm proposed for use in making recommendations via Netflix and Amazon.
The dying cells send signals to recipient tumor cells to increase aggressiveness, motility, and resistance to radiation or chemotherapy.
By using an injected biomarker, researchers are able to have a more accurate reading of kidney function in a clinical setting in half the time it used to take.
Two Novel Research grants from the Lupus Research Alliance boost the study of this complex disease.
UAB’s team found that smartphone motion sensors may pose a threat to speech privacy only if devices are sharing the same surface.
Such analysis, researchers say, can help identify pathogen contact points between species, including pathogens causing human disease.
UAB researchers have identified a subgroup of heart failure patients with reductive stress who may be less responsive or even harmed by antioxidants, which could lead to personalized treatment and better outcomes.
UAB economists show the benefits of gun purchase delay policy in relation to suicide rates.
A UAB researcher is heading to Cameroon to study the effects and safety of antibiotics on pregnant women at risk of contracting malaria.
The bridge between the legal environment and opportunism exists in formal or informal agreements, according to new study.
A team of UAB researchers identified cholesterol-lowering therapies for rheumatoid arthritis patients at risk of developing cardiovascular disease.
The clinical trial attempts to persistently lower the serum uric acid level in patients.
A neuron model of Parkinson’s disease and Lewy body dementias shows defects that could suggest treatments to halt or reverse cognitive impairments before the neurons die.
Courtney Peterson, Ph.D., says eating dinner in the mid-afternoon and fasting for the rest of the day is good for your metabolism.
The UAB-led clinical trial intends to provide multiple myeloma patients a treatment plan that eradicates their disease and enables them to live a life without ongoing treatment.
Page 16 of 49